Compare Heron Therapeutics Inc (HRTX) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Heron Therapeutics IncTrade

Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Intuitive Surgical, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Intuitive Surgical, Inc. trades at $401.27 (market cap $141.75B). The key difference: Intuitive Surgical, Inc. is far larger — about 2306× Heron Therapeutics Inc's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

	HRTX	ISRG
Market Cap	$61.47M	$141.75B
Sector	Health	Health
52-Week High	$1.49	$592.85
52-Week Low	$0.32	$332.02
Enterprise Value	$168.21M	$136.53B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.3409, up 3.24% today, but faces bearish technical signals with 18 sell indicators versus 6 buys. The company reported Q2 2026 revenue of $37.7 million but missed earnings expectations with a $0.03 per share loss. Despite strong analyst support (94.7% buy ratings), fundamental challenges persist with negative net income margins and elevated EV/EBITDA of 34.03.

Investment outlook remains cautious due to consistent earnings misses and negative cash flow from operations. The primary opportunity lies in analyst optimism and potential product growth, while risks include ongoing profitability challenges and competitive pressures in the biotechnology sector.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $401.46, up 2.05% today, with strong quarterly earnings beats and bullish analyst consensus. The stock shows robust revenue growth, expanding margins, and solid cash flow, supported by the da Vinci 5 system adoption. Technical indicators are mixed, with RSI signaling overbought conditions but moving averages bullish.

Outlook remains positive due to durable demand and innovation, though high valuation and competition pose risks. Upside to the $518.10 consensus target offers potential, but investors should weigh premium multiples against growth sustainability.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 2 days agoBearish View details →

ISRG

Deutsche Bank upgrades Intuitive Surgical to Buy as valuation drops amid market challengesGordon Thompson · 9 hours agoBullish Intuitive Surgical rated Hold with 9.17% upside, driven by growth in ASC procedures and limited remanufacturing risks.Seeking Alpha · 12 hours agoBullish Intuitive Surgical stock drops 30% YTD but shows strong growth and recurring revenue in surgical robotics.24/7 Wall Street · 1 day agoBullish View details →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.